Drug class
Anti-vertigo agent; histaminergic ligand
Mechanism of action
The mechanism is only partly understood. Betahistine acts as a partial histamine H1-receptor agonist and H3-receptor antagonist, increasing histamine turnover and release; it may also improve cochlear and cerebral blood flow.
General use cases
- Ménière’s syndrome (symptoms may include vertigo, tinnitus, hearing loss and nausea)
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
